• AstraZeneca's Camizestrant Shows Positive Interim Results In SERENA-6 Phase 3 Trial

    来源: NASDAQ US Markets / 26 2月 2025 02:43:24   America/New_York

    (RTTNews) - AstraZeneca plc (AZN, AZN.L), on Wednesday, reported positive high-level results from a planned interim analysis of the SERENA-6 Phase III trial of Of Camizestrant. https://www.nasdaq.com/articles/astrazenecas-camizestrant-shows-positive-interim-results-serena-6-phase-3-trial
分享